SAKAR HEALTHCARE
|
The Current P/S Ratio of SAKAR HEALTHCARE is 3.92.
Share Price | ₹333.8 | Aug 25,2025 |
Market Cap | ₹740.9 Cr | |
Sales-TTM | ₹189.2 Cr | TTM-Consolidated Results |
Price/Sales | 3.92x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SAKAR HEALTHCARE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹740.9 Cr] as on Aug 25,2025
(/) Sales [ ₹189.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.92x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay '3.92 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SAKAR HEALTHCARE !
The chart below summarizes the trend in P/S Ratio of SAKAR HEALTHCARE over the last five years.
Historical PS (Price/Sales) ratio chart of SAKAR HEALTHCARE
PS Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.53x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 1.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 5.22x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 0.9x.
How does SAKAR HEALTHCARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SAKAR HEALTHCARE | 189.2 | 3.92 | 740.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.39 | 397,498.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 17.18 | 165,838.0 |
CIPLA LTD | 27,811.2 | 4.65 | 129,330.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.50 | 124,235.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.20 | 107,211.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.15 | 105,553.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.36 | 102,978.0 |
LUPIN LTD | 23,375.9 | 3.84 | 89,724.9 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.94 | 61,991.9 |
ABBOTT INDIA LTD | 6,589.9 | 10.17 | 66,994.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAKAR HEALTHCARE 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.94x |
Max industry PS | 17.18x |
Median industry PS | 4.65x |
Average industry PS | 6.84x |
You may also like the below Video Courses